<DOC>
	<DOCNO>NCT01909154</DOCNO>
	<brief_summary>The purpose study confirm security , detect effect local administration damage nervous tissue , autologous bone marrow stromal cell .</brief_summary>
	<brief_title>Safety Study Local Administration Autologous Bone Marrow Stromal Cells Chronic Paraplegia</brief_title>
	<detailed_description>It clinical trial phase I , single center , non-randomized , uncontrolled , open prospective follow-up cohort patient chronic spinal cord injury ( SCI ) treat autologous stromal cell bone marrow administrate locally ( subarachnoid intramedullar ) intrathecal microinjection three month later , lumbar subarachnoid administration . The minimum follow-up duration patient 12 month first administration , death , occur .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Male female age 18 year 60 year age old functional sequela chronically establish traumatic injury spinal cord ( spinal segment vertebral body C6 L1 ) consider irreversible ( respond treatment ) . In study , lesion consider chronically establish , sign functional recovery minimum followup period 6 month spinal cord injury . The upper age limit justify low potential vitro expansion bone marrow stromal cell 60 year . Complete paraplegia , loss motor sensory function lesion ( grade A American Spinal Injury Association Impairment ( ASIA ) Scale . Spinal injury MRI morphologically visible , without image suggest spinal cord transection , separation end spinal cord . Tracking evolutionary possibility treatment protocol comply physiotherapy maintain throughout follow period . Written inform Consent accord good clinical practice ( GCP ) local regulation , obtain study procedure . Hematological parameter creatinine , serum glutamate oxaloacetate transaminase ( SGOT ) serum glutamate pyruvate transaminase ( SGPT ) normal range accord laboratory standard , accept , however , small nonsignificant deviation accord investigator . Exclusion criterion : Pregnancy lactation Systemic disease represent added risk treatment Patients question possible cooperation rehabilitationphysiotherapy treatment later , negative report psychological assessment prior . Neuroimaging data show spinal cord section separation terminal portion spinal cord Current neoplastic disease diagnose treat previous five year Patients treat hematopoietic growth factor require stable anticoagulation Added neurodegenerative disease History substance abuse , psychiatric illness allergy protein product use process cell expansion HIV positive serology syphilis Hepatitis B Hepatitis C active According investigator 's opinion finding physical examination , abnormal clinical test result medica relevant entry , social psychosocial factor might influence negatively study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>neurophysiological parameter improvement</keyword>
	<keyword>spinal cord injury</keyword>
	<keyword>biology therapy</keyword>
</DOC>